[Giant bladder carcinosarcoma].

V Hernández Cańas; M Alvarez Ardura; J M De la Morena Gallego; E De la Peña Zarzuelo; P Domínguez Franjo; C Llorente Abarca

doi:10.1016/s0210-4806(06)73510-0

Home/Archive/PubMed

PubMed · 16921847

[Giant bladder carcinosarcoma].

V Hernández Cańas·M Alvarez Ardura·J M De la Morena Gallego·E De la Peña Zarzuelo·P Domínguez Franjo·C Llorente Abarca

View original source ↗Export metadata ↓

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

Carcinosarcoma Female Humans Middle Aged Urinary Bladder Neoplasms Case Reports Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

V Hernández Cańas, M Alvarez Ardura, J M De la Morena Gallego, E De la Peña Zarzuelo, P Domínguez Franjo, C Llorente Abarca. 2006. [Giant bladder carcinosarcoma].. https://doi.org/10.1016/s0210-4806(06)73510-0

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Serous ovarian carcinoma recurring as a heterologous carcinosarcoma.

Only two cases of recurrence of heterologous carcinosarcoma from adenocarcinoma of the ovary have been documented in the published literature. We report a case of serous ovarian carcinoma recurring as a heterologous carcinosarcoma. The immunohistochemical analysis of several biological parameters in primary ovarian adenocarcinoma and recurrent carcinosarcoma has been also performed.

Carcinosarcoma↗

PubMed2006

Aggressive carcinosarcoma of the uterine cervix associated with high levels of granulocyte colony stimulating factor: case report and laboratory correlates.

BACKGROUND: Production of granulocyte colony stimulating factor (G-CSF) by solid tumors, including cervix cancers, is reported to be associated with an aggressive clinical course. CASE: A 64-year-old female with a locally advanced carcinosarcoma of the cervix presents with a WBC count of 48,000 cells/microl with no infectious causes. Her WBCs returned to normal during primary radiotherapy and then increased again with recurrence. She expired of progressive disease 10 weeks after primary therapy. Serum and pleural fluid levels of G-CSF were 1500 and 6000 pg/ml, respectively. Cancer cells secreted G-CSF in culture and recombinant G-CSF increased cancer cell proliferation. CONCLUSIONS: Like other sarcomas, carcinosarcomas can produce high levels of G-CSF and demonstrate an aggressive behavior that may be autocrine stimulation.

Carcinosarcoma↗

PubMed2006

A case with sinonasal teratocarcinosarcoma in the nasal cavity and ethmoid sinus.

Sinonasal teratocarcinosarcoma (SNTCS) is a rare and aggressive malignant neoplasm histologically characterized by the combination of one or more epithelial elements and mesenchymal components. We report a 61-year-old man with SNTCS involving left nasal cavity and ethmoid sinus. He complained of left epistaxis for 1 week. Computed tomography and magnetic resonance imaging revealed a soft tissue filling the left middle meatus and ethmoid sinus, and effusion in the left sphenoid sinus but no invasion to the orbit or skull base. Tumor was completely removed with lateral rhinotomy, and post-operative radiation therapy (Liniac 60 Gy) was performed. Follow-up examination for 3 years and 5 months after the radiation therapy has shown no evidence of recurrence or metastasis. This report describes his clinical course, etiology, diagnosis and management of SNTCS with a review of literature.

Carcinosarcoma↗